Skip to main navigation
Upstazaâ„¢ Granted Marketing Authorization by European Commission as First Disease-Modifying Treatment for AADC Deficiency
  • Sign Up for Alerts
  • Clinical Trials
  • Investors
PTC Therapeutics Facebook PTC Therapeutics LinkedIn PTC Therapeutics Twitter
Toggle Menu
  • Our Company
    • About PTC Therapeutics
      • Patient-Centric Approach
      • Responsibility
      • Global Compliance Program
    • Grants, Donations and Awards
      • STRIVE Awards Program
      • Investigator Initiated Studies (IIS)
    • Leadership
    • Contact Us
    • Locations
  • Our Science
    • Expertise
      • Alternative Splicing Programs
      • Bio-e Electron Transfer
      • Gene Therapy
      • Nonsense Readthrough
      • Transcript Regulators
    • Therapeutic Areas
  • Our Pipeline
    • Portfolio Pipeline
    • Approved Medicines
    • Clinical Trials
  • News & Resources
    • Newsroom
    • Press Releases
    • Resources for Patients
    • Resources for Health Care Professionals
  • Careers
    • Careers with Purpose
    • Fellowship
Banner

Committee Composition

Committee Composition

Audit Committee Compensation Committee Nominating and Corporate Governance Committee
Emma Reeve Audit Committee
Alethia Young Audit Committee
Stephanie Okey Nominating and Corporate Governance Committee
Michael Schmertzler Compensation Committee Nominating and Corporate Governance Committee
Mary Smith Audit Committee Compensation Committee
David P. Southwell Audit Committee Compensation Committee
Glenn D. Steele JR., MD, Ph.D Compensation Committee
Dawn Svoronos Nominating and Corporate Governance Committee
Jerome B. Zeldis Ph.D. Nominating and Corporate Governance Committee
= Chairperson = Member = Chairman of the Board

Investor Relations

  • Investors
  • Press Releases
  • Events & Presentations
  • Governance / Compliance
    • Management
    • Board of Directors
    • Committee Composition
    • Contact the Board
  • Financial Information
  • Annual Report and Proxy
  • Sustainability Report
  • Stock Information
  • Investor FAQs
  • Contact Us

Shareholder Tools

Shareholder Tools

Printed Materials
Email Alerts
RSS
Print
Share
  • Facebook
  • LinkedIn
  • Twitter
  • RSS
About PTC Therapeutics Investors Expertise Newsroom Portfolio Pipeline Careers
© 2022 PTC Therapeutics. All rights reserved.
Terms of Use